Communicated by Albert H. Coons, February 16, 1972 ABSTRACT Spleen cells from BALB/c or CAF1 mice released little or no detectable leukemia virus when cultured 2-7 days in vitro. In contrast, spleen cells of CAF1 mice previously inoculated with parental BALB/c spleen cells released leukemia viruses in 10 of 11 cases studied. Cultures of a mixture of spleen cells from normal BALB/c and CAF1 mice also contained leukemia viruses. Phytohemagglutinin induced the transformation of lymphocytes in cultures of CAF1 or BALB/c spleen cells, but this transformation did not activate leukemia viruses. It is concluded that mixed lymphocyte cultures in vitro, just as graft-versushost reactions in vivo, can activate leukemia viruses that are normally present in a repressed form. This activation is not solely a function of lymphocyte transformation. The activated mouse leukemia virus may subsequently account for the observed high incidence of neoplasia in graft-versus-host disease.
Many strains of mice carry C-type RNA leukemia viruses, which are detectable by various techniques (1, 2) . In other strains, such viruses are not detectable under ordinary circumstances, but they can be activated in vivo by exposure to radiation or chemical carcinogens (2) (3) (4) (5) (6) , or in vitro by aging, infection with other viruses, or exposure to chemicals such as 5-bromodeoxyuridine (BrdU) or 5-iododeoxyuridine (IdU) (7) (8) (9) (10) .
We have recently shown that murine leukemia viruses are also activated by the graft-versus-host reaction, an immunological response induced by transplantation of immunocompetent cells into recipients unable to react against them (11) . The graft-versus-host reaction can be studied in F1 hybrid recipients of parental immunocytes, because F1 hybrids of highly inbred mice are unable to reject parental grafts, whereas lymphocytes in the inoculum of parental spleen cells respond with immunological specificity to antigens possessed by the hybrid recipient. We studied (BALB/c x A/J)Fl hybrid mice, 6-8 weeks old (hereafter referred to as CAF1) that were inoculated with parental BALB/c spleen cells. Leukemia viruses became readily detectable in the injected hosts within a week after inoculation, and a high incidence of reticulum-cell sarcomas developed at a relatively early age; 30% of the mice had lymphomas by 12 months and 80% had lymphomas by 24 months (11, 12) . In contrast, OAF1 mice that were not inoculated with parental cells remained virusfree at least until 12 months of age, and they had a low incidence of lympho-reticular neoplasms that occurred late in life (0% under 12 months of age, less than 5% between 12-24 months).
In the present investigations, we have examined whether leukemia viruses could also be detected when spleen cells of CAF1 mice undergoing a graft-versus-host reaction were cultured in vitro. The possibility that leukemia viruses could be activated by the in vitro analogue of the graft-versus-host reaction-the mixed lymphocyte culture-was also studied. In addition, the influence of the lymphocyte mitogen phytohemagglutinin(PHA) on the activation of leukemia viruses in cultured mouse lymphocytes was studied.
MATERIALS AND METHODS
Mice. BALB/c, A/J, C57B1/6, DBA/2, CAF1, and (C57B1/6 x DBA/2)F1 (hereafter referred to as BDF1) mice were obtained from Jackson Laboratories, Bar Harbor, Maine. CD (R)_1 Swiss mice were obtained from Charles River Farms, Boston, Mass. 6-to 8-week-old CAF1 mice received 4 weekly intraperitoneal injections of 50 X 106 viable spleen cells prepared as described (13) with Hank's medium (pH 7.2), and precipitated with 10% C13CCOOH and absolute alcohol. The glass-filter discs were placed in vials, and radioactivity was assessed by standard liquid scintillation techniques. Cultures with PHA were assayed after 2 days in culture, and mixed lymphocyte cultures were assayed after 3-7 days in culture.
Leukemia Virus Assays. Lymphocyte cultures were tested for leukemia virus by the mixed-culture cytopathogenicity assay reported by Klement et al. (17) and described more fully in (11) . XC cells were provided by Dr. W. P. Rowe. Spleen-cell suspensions from allogenic and normal BDF1 mice were also tested for virus by this technique. Experimental and control cells were examined under a light microscope at a magnification of X 100, and multinucleate cells (more than four nuclei per cell) were counted per 100 fields per dish. A given sample (dilution) was considered positive for virus if the number of multinucleate cells per dish was four times the mean of the number of multinucleate cells in the control.
The same samples were also tested for leukemia viruses by a focus assay on mouse cells transformed by murine sarcoma virus, but not releasing infectious virus (sarcoma positiveleukemia negative cells, provided by Dr. R. Bassin) (18) . Cells were plated in 60-mm petri dishes (Falcon Plastics) at a density of 105 cells per dish and were infected the following day. Lytic lesions, easily seen by light microscopy, appeared 4-5 days after inoculation. Positive and negative controls, as in the mixed-culture cytopathogenicity assay, were included in each assay. After several weeks evidence was obtained indicating that the sarcoma-positive, leukemia-negative cells were contaminated with mycoplasma, and this assay was discontinued. Before that, there was concordance between the results from the mixed-culture cytopathogenicity assays and those from the cultures of sarcoma-positive, leukemia-negative cells. RESULTS
Activation of leukemia virus during the graft-versus-host reaction
Cultures of spleen cells from uninoculated CAF1 and BALB/c mice were found to be negative for leukemia viruses (Table 1) by the mixed-culture cytopathogenicity or transformed-cell extend the in vivo findings to their probable in vitro counterpart, the mixed-lymphocyte reaction. The mechanism(s) of virus activation by these immunological reactions remain to be fully elucidated; however, activation does not appear to be solely the result of the transformation of lymphocytes, because PHA induced marked blast transformation in CAF1 lymphocytes, yet activation of virus did not occur. Furthermore, PHA did not increase the titer of recoverable leukemia virus in lymphocytes from mice undergoing graftversus-host reaction.
Not only is the extent of lymphocyte transformation in the mixed-lymphocyte cultures less than that induced by PHA (20) , but some qualitative difference between the two systems must also exist, since leukemia virus was recoverable only from mixed-lymphocyte cultures. Since it is estimated that less than 2% of an initial lymphoid population can respond to an antigenic stimulation, whereas an excess of 80% can respond to PHA (20) , the metabolic demands and products of metabolism may vary between the two systems as well. Perhaps the balance of these products known to directly stimulate or inhibit lymphocyte metabolism (21, 22) Is the immunologically-activated leukemia virus the cause of the lymphomas that develop in CAF1 mice inoculated with BALB/c cells? Treatments that prevent cellular proliferation and virus activation, e.g., treatment of donor cells with mitomycin C, also prevent the graft-versus-host reaction and development of lymphoma (12) . In addition, tumor cells from CAF1 mice with the graft-versus-host reaction induced rat-type lymphosarcomas when inoculated into newborn Wistar-Furth rats, a strain highly susceptible to murine viruses (R. S. Schwartz, unpublished results); mature C-type particles were seen by electron microscopy in these rat tumors. It is of interest that activation of leukemia viruses was not detected frequently in a parent-hybrid combination in which lymphomas do not develop. For example, none of 81 (C57B1/6 x DBA/2)F1 mice developed a lymphoma after the administration of DBA/2 spleen cells (R. S. Schwartz, in preparation), and in this combination leukemia virus was not detected frequently either in vivo or in vitro. This result shows that not all graft-versus-host reactions or mixed-lymphocyte cultures will be associated with the activation of leukemia viruses, and again demonstrates that lymphocyte transformation, although necessary for viral activation, is not the sole requirement for this phenomenon. Further evidence that the viruses activated during the graft-versushost reactions are relevant to the development of neoplasms in this condition was recently provided by the demonstration that cell-free extracts of the spleens of OAF1 mice that had been. injected with BALB/c spleen cells induced lymphomas when injected into newborn CAF1 mice (23 (24, 25) might be explained on the basis of our findings. Moreover, the increased incidence of neoplasms in recipients of renal allografts (26) -commonly attributed to immunosuppression -may be due to activation of leukemia viruses during the overt or subtle transplantation reactions in these patients. Finally, the recent report of Fialkow et al. (27) , in which donor bone marrow cells became leukemic after grafting into a previously irradiated leukemic recipient, also suggest activation of leukemia viruses as a possible mechanism.
